Goldman Sachs Downgrades Xylem (XYL) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts XYL Hot Sheet
Price: $101.05 +4.97%
Rating Summary:
16 Buy, 24 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
16 Buy, 24 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
Goldman Sachs analyst Brian Lee downgraded Xylem (NYSE: XYL) from Neutral to Sell with a price target of $56.00 (from $77.00).
For an analyst ratings summary and ratings history on Xylem click here. For more ratings news on Xylem click here.
Shares of Xylem closed at $66.19 yesterday.
You May Also Be Interested In
- Argus Downgrades Xylem (XYL) to Hold
- Oriental Land Co Ltd. (4661:JP) (OLCLY) PT Raised to JPY5,100 at JPMorgan
- Sodexo (SW:FP) (SDXAY) PT Raised to EUR55.50 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
